Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 875

1.

Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.

Gambacciani M, Ciaponi M, Cappagli B, Genazzani AR.

Am J Obstet Gynecol. 2001 Nov;185(5):1180-5.

PMID:
11717654
[PubMed - indexed for MEDLINE]
2.

Postmenopausal femur bone loss: effects of a low dose hormone replacement therapy.

Gambacciani M, Ciaponi M, Cappagli B, Monteleone P, Benussi C, Bevilacqua G, Genazzani AR.

Maturitas. 2003 Jul 25;45(3):175-83.

PMID:
12818462
[PubMed - indexed for MEDLINE]
3.

Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women.

Lindsay R, Gallagher JC, Kleerekoper M, Pickar JH.

JAMA. 2002 May 22-29;287(20):2668-76.

PMID:
12020302
[PubMed - indexed for MEDLINE]
4.

Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial.

Grey AB, Stapleton JP, Evans MC, Tatnell MA, Reid IR.

Ann Intern Med. 1996 Sep 1;125(5):360-8.

PMID:
8702086
[PubMed - indexed for MEDLINE]
5.

Continuous combined oestrogen/progestin therapy is well tolerated and increases bone density at the hip and spine in post-menopausal osteoporosis.

Grey AB, Cundy TF, Reid IR.

Clin Endocrinol (Oxf). 1994 May;40(5):671-7.

PMID:
8013147
[PubMed - indexed for MEDLINE]
6.

Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.

Gambacciani M, Cappagli B, Ciaponi M, Pepe A, Vacca F, Genazzani AR.

Maturitas. 2008 Jan 20;59(1):2-6. Epub 2007 Dec 3.

PMID:
18063490
[PubMed - indexed for MEDLINE]
7.

Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen.

Gallagher JC, Kable WT, Goldgar D.

Am J Med. 1991 Feb;90(2):171-8.

PMID:
1847582
[PubMed - indexed for MEDLINE]
9.

Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: four-year follow-up and comparison with healthy postmenopausal women.

Orr-Walker BJ, Evans MC, Clearwater JM, Horne A, Grey AB, Reid IR.

Arch Intern Med. 2000 Jul 24;160(14):2161-6.

PMID:
10904459
[PubMed - indexed for MEDLINE]
10.

Ethnic differences in levels of bone and cartilage biomarkers and hormonal responsiveness in nine groups of postmenopausal Asian women: the Pan-Asia Menopause (PAM) study.

Holinka CF, Christiansen C, Tian XW, Ausmanas MK.

Climacteric. 2008 Feb;11(1):44-54. doi: 10.1080/13697130701744886.

PMID:
18202964
[PubMed - indexed for MEDLINE]
11.

[Absence of antiosteopenic effect of hormone replacement therapy in postmenopausal women].

Ortiz Núñez DA, Mengchún López G, Hernández Marín I, Mendoza R, Ayala Ruíz AR.

Ginecol Obstet Mex. 2004 Jul;72:349-55. Spanish.

PMID:
15469174
[PubMed - indexed for MEDLINE]
12.

Effects on bone of oral hormone replacement therapy initiated 2 years after ovariectomy in young adult monkeys.

Jayo MJ, Register TC, Carlson CS.

Bone. 1998 Oct;23(4):361-6.

PMID:
9763148
[PubMed - indexed for MEDLINE]
13.

A 3-year study of prevention of postmenopausal bone loss: conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone.

Thiébaud D, Bigler JM, Renteria S, Pache T, Welti HJ, Landry M, Burckhardt P.

Climacteric. 1998 Sep;1(3):202-10.

PMID:
11907945
[PubMed - indexed for MEDLINE]
14.

The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women. A randomized, controlled trial.

Recker RR, Davies KM, Dowd RM, Heaney RP.

Ann Intern Med. 1999 Jun 1;130(11):897-904.

PMID:
10375338
[PubMed - indexed for MEDLINE]
15.

A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.

Baracat EC, Barbosa IC, Giordano MG, Haidar MA, Marinho RM, Menegocci JC, Morais KM, Tomaz G, Wehba S.

Climacteric. 2002 Mar;5(1):60-9. Erratum in: Climacteric 2002 Jun;5(2):vi.

PMID:
11974560
[PubMed - indexed for MEDLINE]
16.

Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women.

Gambacciani M, Ciaponi M, Cappagli B, Monteleone P, Benussi C, Bevilacqua G, Vacca F, Genazzani AR.

Maturitas. 2005 Feb 14;50(2):91-7.

PMID:
15653005
[PubMed - indexed for MEDLINE]
17.

Medroxyprogesterone acetate enhances the spinal bone mineral density response to oestrogen in late post-menopausal women.

Grey A, Cundy T, Evans M, Reid I.

Clin Endocrinol (Oxf). 1996 Mar;44(3):293-6.

PMID:
8729524
[PubMed - indexed for MEDLINE]
18.

Comparison of the effect of raloxifene and continuous-combined hormone therapy on mammographic breast density and breast tenderness in postmenopausal women.

Jackson VP, San Martin JA, Secrest RJ, McNabb M, Carranza-Lira S, Figueroa-Casas P, Fernandes CE, Romaguera J.

Am J Obstet Gynecol. 2003 Feb;188(2):389-94. Erratum in: Am J Obstet Gynecol. 2003 Jun;188(6):1628.

PMID:
12592245
[PubMed - indexed for MEDLINE]
19.

Comparative effects of continuous combined hormone therapy and tibolone on body composition in postmenopausal women.

Ziaei S, Moaya M, Faghihzadeh S.

Climacteric. 2010 Jun;13(3):249-53. doi: 10.3109/13697130903318240.

PMID:
19848555
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk